Migraine Briefs

Migraine linked to increased hypertension risk in menopausal women


 

Key clinical point: Menopausal women with migraine are at a higher risk for incident hypertension.

Major finding: Migraine was associated with an increased risk for incident hypertension (hazard ratio migraine, 1.29; 95% confidence interval, 1.24-1.35) in menopausal women.

Study details: Findings are from a longitudinal cohort study of 56,202 menopausal women free of hypertension or cardiovascular disease at the age of menopause who participated in the French E3N cohort.

Disclosures: The authors reported no targeted funding. CJ MacDonald and T Kurth received funding and/or honoraria from multiple sources. Other authors had no disclosures relevant to the manuscript.

Source: MacDonald CJ et al. Neurology. 2021 Apr 21. doi: 10.1212/WNL.0000000000011986 .

Recommended Reading

Erenumab shows long-term promise in episodic migraine patients with prior treatment failures
Migraine ICYMI
Migraine: Repeated transcranial direct current stimulation effectively reduces pain intensity
Migraine ICYMI
Fremanezumab beneficial for patients with migraine and comorbid depression
Migraine ICYMI
Galcanezumab shows promise in a real-life cohort of patients with migraine
Migraine ICYMI
Chronic migraine: Medication-overuse headache linked to increased suicidal risks
Migraine ICYMI
Migraine: Galcanezumab effective in patients refractory to prior preventive treatments
Migraine ICYMI
No increased risk of hypertension with erenumab?
Migraine ICYMI
BBB integrity linked to cortical spreading depression
Migraine ICYMI
COVID-19 vaccines are safe and effective for patients with migraine
Migraine ICYMI
Women with migraine are ‘high-risk’ patients during pregnancy
Migraine ICYMI